David F. Chang, MD

VIENNA — In this Healio Video Perspective from the ESCRS meeting, David F. Chang, MD, speaks about operating room waste reduction through reusing materials and equipment.

A study evaluated the carbon footprint associated with in-person and virtual meetings of the American Academy of Ophthalmology and suggested strategies to reduce greenhouse gas emissions in the future.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview David F. Chang, MD.

In this episode, Susan M. MacDonald, MD, and Laura B. Enyedi, MD, talk with Randall J. Olson, MD, William Trattler, MD, David F. Chang, MD, and Thomas A. Oetting, MS, MD, about the importance of providing mentorship, advocacy and leadership opportunities to women in ophthalmology.

The Ridley Medal Lecture gave David Chang, MD, an opportunity to share the accomplishments of what he considers the greatest team of cataract surgeons in the world, those at Aravind Eye Care System in southern India.

KOLOA, Hawaii — At Hawaiian Eye 2020, David F. Chang, MD, discusses and demonstrates how he manages toric IOL misalignment.

ORLANDO — In his video presentation from Cataract Surgery: Telling It Like It Is, David F. Chang, MD, shows how to perform a viscoelastic posterior levitation technique for lens removal after a posterior capsule rupture during cataract surgery.

It is with brunescent nuclei that surgeons are most interested in improved phaco technology because these cases pose the stiffest test of our skills and equipment. Virtually every surgical step is more difficult and complication prone.

Patient selection would be much easier if we had a powerful accommodating IOL. Optical quality would not be compromised by nighttime halos or reduced contrast sensitivity. Patients could dynamically shift their focus along a continuous range of distances from far to near. The deciding factor would simply be the patient’s desire and willingness to pay for this convenience.

Topical nonsteroidal anti-inflammatory drugs have been proven to be invaluable medications for cataract surgeons and their patients. As a class, these drugs prevent intraoperative miosis and are effective as both intraoperative and postoperative analgesics. Their potent anti-inflammatory effects make NSAIDs useful in controlling postoperative iritis. Yet of all the clinical benefits, the primary reason that most cataract surgeons use NSAIDs is for the prevention and management of postoperative cystoid macular edema (CME).